See leaflet
See Risk Management Plan
Roxifer®
deferasirox
Indications
- Treatment of Chronic Iron Overload secondary to transfusions.
- Treatment of Chronic Iron Overload in non-transfusion-dependent thalassemic syndromes.
Presentations
- 250 mg x 28 tablets for oral suspension
- 500 mg x 28 tablets for oral suspension
- 250 mg x 28 tablets for oral suspension
- 500 mg x 28 tablets for oral suspension
